318 related articles for article (PubMed ID: 11116051)
1. Endoglin is overexpressed after arterial injury and is required for transforming growth factor-beta-induced inhibition of smooth muscle cell migration.
Ma X; Labinaz M; Goldstein J; Miller H; Keon WJ; Letarte M; O'Brien E
Arterioscler Thromb Vasc Biol; 2000 Dec; 20(12):2546-52. PubMed ID: 11116051
[TBL] [Abstract][Full Text] [Related]
2. Endoglin, a TGF-beta receptor-associated protein, is expressed by smooth muscle cells in human atherosclerotic plaques.
Conley BA; Smith JD; Guerrero-Esteo M; Bernabeu C; Vary CP
Atherosclerosis; 2000 Dec; 153(2):323-35. PubMed ID: 11164421
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effects of tranilast on expression of transforming growth factor-beta isoforms and receptors in injured arteries.
Ward MR; Sasahara T; Agrotis A; Dilley RJ; Jennings GL; Bobik A
Atherosclerosis; 1998 Apr; 137(2):267-75. PubMed ID: 9622270
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin II via activation of type 1 receptor upregulates expression of endoglin in human coronary artery endothelial cells.
Li D; Chen H; Mehta JL
Hypertension; 2001 Nov; 38(5):1062-7. PubMed ID: 11711498
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional activation of endoglin and transforming growth factor-beta signaling components by cooperative interaction between Sp1 and KLF6: their potential role in the response to vascular injury.
Botella LM; Sánchez-Elsner T; Sanz-Rodriguez F; Kojima S; Shimada J; Guerrero-Esteo M; Cooreman MP; Ratziu V; Langa C; Vary CP; Ramirez JR; Friedman S; Bernabéu C
Blood; 2002 Dec; 100(12):4001-10. PubMed ID: 12433697
[TBL] [Abstract][Full Text] [Related]
6. Adenovirus-mediated gene transfer of a secreted transforming growth factor-beta type II receptor inhibits luminal loss and constrictive remodeling after coronary angioplasty and enhances adventitial collagen deposition.
Kingston PA; Sinha S; David A; Castro MG; Lowenstein PR; Heagerty AM
Circulation; 2001 Nov; 104(21):2595-601. PubMed ID: 11714656
[TBL] [Abstract][Full Text] [Related]
7. Soluble transforming growth factor-beta type II receptor inhibits negative remodeling, fibroblast transdifferentiation, and intimal lesion formation but not endothelial growth.
Smith JD; Bryant SR; Couper LL; Vary CP; Gotwals PJ; Koteliansky VE; Lindner V
Circ Res; 1999 May; 84(10):1212-22. PubMed ID: 10347096
[TBL] [Abstract][Full Text] [Related]
8. Neuron-derived orphan receptor-1 (NOR-1) modulates vascular smooth muscle cell proliferation.
Martínez-González J; Rius J; Castelló A; Cases-Langhoff C; Badimon L
Circ Res; 2003 Jan; 92(1):96-103. PubMed ID: 12522126
[TBL] [Abstract][Full Text] [Related]
9. Endoglin promotes endothelial cell proliferation and TGF-beta/ALK1 signal transduction.
Lebrin F; Goumans MJ; Jonker L; Carvalho RL; Valdimarsdottir G; Thorikay M; Mummery C; Arthur HM; ten Dijke P
EMBO J; 2004 Oct; 23(20):4018-28. PubMed ID: 15385967
[TBL] [Abstract][Full Text] [Related]
10. Endoglin is a component of the transforming growth factor (TGF)-beta receptor complex of human pre-B leukemic cells.
Zhang H; Shaw AR; Mak A; Letarte M
J Immunol; 1996 Jan; 156(2):564-73. PubMed ID: 8543807
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor-betas and CD105 expression in calcification and bone formation in human atherosclerotic lesions.
Jeziorska M
Z Kardiol; 2001; 90 Suppl 3():23-6. PubMed ID: 11374028
[TBL] [Abstract][Full Text] [Related]
12. Beta ig-h3, a transforming growth factor-beta-inducible gene, is overexpressed in atherosclerotic and restenotic human vascular lesions.
O'Brien ER; Bennett KL; Garvin MR; Zderic TW; Hinohara T; Simpson JB; Kimura T; Nobuyoshi M; Mizgala H; Purchio A; Schwartz SM
Arterioscler Thromb Vasc Biol; 1996 Apr; 16(4):576-84. PubMed ID: 8624780
[TBL] [Abstract][Full Text] [Related]
13. Regulation of bovine corneal endothelial cell cycle by transforming growth factor-beta.
Motegi Y; Usui T; Ishida K; Kato S; Yamashita H
Acta Ophthalmol Scand; 2003 Oct; 81(5):517-25. PubMed ID: 14510802
[TBL] [Abstract][Full Text] [Related]
14. Significant expression of endoglin (CD105), TGFbeta-1 and TGFbeta R-2 in the atherosclerotic aorta: an immunohistological study.
Piao M; Tokunaga O
J Atheroscler Thromb; 2006 Apr; 13(2):82-9. PubMed ID: 16733295
[TBL] [Abstract][Full Text] [Related]
15. Endoglin is an accessory protein that interacts with the signaling receptor complex of multiple members of the transforming growth factor-beta superfamily.
Barbara NP; Wrana JL; Letarte M
J Biol Chem; 1999 Jan; 274(2):584-94. PubMed ID: 9872992
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of protein tyrosine kinases attenuates increases in expression of transforming growth factor-beta isoforms and their receptors following arterial injury.
Ward MR; Agrotis A; Kanellakis P; Dilley R; Jennings G; Bobik A
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2461-70. PubMed ID: 9409216
[TBL] [Abstract][Full Text] [Related]
17. Adenovirus-mediated gene transfer of transforming growth factor-beta3, but not transforming growth factor-beta1, inhibits constrictive remodeling and reduces luminal loss after coronary angioplasty.
Kingston PA; Sinha S; Appleby CE; David A; Verakis T; Castro MG; Lowenstein PR; Heagerty AM
Circulation; 2003 Dec; 108(22):2819-25. PubMed ID: 14638551
[TBL] [Abstract][Full Text] [Related]
18. Molecular characterization and in situ localization of murine endoglin reveal that it is a transforming growth factor-beta binding protein of endothelial and stromal cells.
St-Jacques S; Cymerman U; Pece N; Letarte M
Endocrinology; 1994 Jun; 134(6):2645-57. PubMed ID: 8194490
[TBL] [Abstract][Full Text] [Related]
19. Endoglin modulates cellular responses to TGF-beta 1.
Lastres P; Letamendía A; Zhang H; Rius C; Almendro N; Raab U; López LA; Langa C; Fabra A; Letarte M; Bernabéu C
J Cell Biol; 1996 Jun; 133(5):1109-21. PubMed ID: 8655583
[TBL] [Abstract][Full Text] [Related]
20. Endoglin expression on human microvascular endothelial cells association with betaglycan and formation of higher order complexes with TGF-beta signalling receptors.
Wong SH; Hamel L; Chevalier S; Philip A
Eur J Biochem; 2000 Sep; 267(17):5550-60. PubMed ID: 10951214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
